ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0067

Functionally Mature CD1c+ Dendritic Cells Contribute to Synovial Inflammation in Rheumatoid Arthritis via STAT3

Mary Canavan1, Viviana Marzaioli1, Vipul Bhargava2, Sunil Nagpal3, Phil Gallagher4, Conor Hurson5, Ronan Mullan6, Douglas Veale7 and Ursula Fearon1, 1Molecular Rheumatology, Trinity College Dublin, Dublin, Dublin, Ireland, 2Janssen Research & Development, Springhouse, PA, 3Janssen Research & Development, Collegeville, PA, 4St Vincents University Hospital, UCD, Dublin, Ireland, 5St Vincents University Hospital, UCD, Dublin, Dublin, Ireland, 6Adelaide and Meath Hospital, Dublin, Dublin, Ireland, 7EULAR Centre for Arthritis and Rheumatic Diseases, St Vincents University Hospital, UCD, Dublin, Dublin, Ireland

Meeting: ACR Convergence 2020

Keywords: Dendritic cells, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Friday, November 6, 2020

Title: Innate Immunity Poster

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Myeloid Dendritic Cells (DC) are potent antigen presenting cells that can be subdivided into CD141+ and CD1c+ DC. We have previously reported an unacknowledged role of CD141+DC in the RA synovium. However, the identification and function of CD1c+ DC in the RA synovium has yet to be fully elucidated. Therefore our aim was to investigate if CD1c+DC reside in the RA synovium and ascertain if they represent a unique population, distinct from peripheral blood CD1c+DC.

Methods: Synovial tissue (ST) biopsies and synovial fluid mononuclear cells (SFMC) were obtained via arthroscopy and healthy control (HC) ST was obtained during ACL surgery. Synovial biopsies were enzymatically and mechanically dissociated to yield a single cell suspension. SFMC and peripheral blood mononuclear cells (PBMC) in addition to synovial tissue digests were stained with a panel of fluorochrome conjugated antibodies and single cell analysis was performed by multicolour flow cytometry. CD1c+DC were sorted from RA SF and peripheral blood (PB) and RNA-sequencing was performed. Principal Component Analysis (PCA), Enriched pathway analysis, heatmaps and hierarchical clustering were identified using the DeSeq2 R package and Ingenuity® Pathway Analysis (IPA). For functional experiments CD1c+DC were magnetically sorted from RA SFMC and RA PBMC and phagocytosis was assessed using flow cytometry. Finally allogeneic T cell cocultures were performed with SF and PB CD1c+DC in the presence or absence of the STAT3 inhibitor Stattic.

Results: CD1c+DC are significantly decreased in RA PB compared to HC PB (p< 0.01) and express significantly higher levels of the chemokine receptors CCR7 (p< 0.05) and CXCR3 (p=0.08) compared to HC DC - suggestive of DC migration to the synovium.  In support of this hypothesis, CD1c+DC were identified in RA ST by multicolour flow cytometry and were significantly increased in RA ST compared to RA PB (p< 0.01). RA ST CD1c+DC express significantly higher expression of the DC activation marker CD80 compared to RA PB (p< 0.01) or HC ST (p< 0.05). CD1c+DC are also enriched in RA synovial fluid compared to RA PB (p< 0.05), express significantly higher levels of the maturation markers CD80,CD83,CD40,PD-L1 and BTLA (all p< 0.05) and are less phagocytic compared to matched PB. RNA-sequencing and PCA analysis revealed distinct transcriptional variation between synovial and PB CD1c+DC. Moreover, IPA analysis revealed an enrichment in the STAT3 pathway in synovial DC. Synovial CD1c+DC induce proinflammatory cytokines (TNFα, GMCSF, IFNγ) from CD4+ T-cells in allogeneic cocultures, and effect which is abrogated in the presence of a STAT3 inhibitor.

Conclusion: CD1c+DC are present in the RA synovium in a mature state, have distinct tissue specific characteristics and mediate their T cell stimulatory capabilities via STAT3.


Disclosure: M. Canavan, None; V. Marzaioli, None; V. Bhargava, None; S. Nagpal, None; P. Gallagher, None; C. Hurson, None; R. Mullan, None; D. Veale, AbbVie, 2, Health Beacon, 1, Janssen, 2, 8, Pfizer, 2, 5, 8, Novartis, 2, 5, 8, UCB, 2, 5; U. Fearon, None.

To cite this abstract in AMA style:

Canavan M, Marzaioli V, Bhargava V, Nagpal S, Gallagher P, Hurson C, Mullan R, Veale D, Fearon U. Functionally Mature CD1c+ Dendritic Cells Contribute to Synovial Inflammation in Rheumatoid Arthritis via STAT3 [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/functionally-mature-cd1c-dendritic-cells-contribute-to-synovial-inflammation-in-rheumatoid-arthritis-via-stat3/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/functionally-mature-cd1c-dendritic-cells-contribute-to-synovial-inflammation-in-rheumatoid-arthritis-via-stat3/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology